sis decm patch product corpatch Search Results


90
CorMatrix Cardiovascular Inc sis decm patch product corpatch
Approved dECM medical devices and devices under clinical trials.
Sis Decm Patch Product Corpatch, supplied by CorMatrix Cardiovascular Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sis decm patch product corpatch/product/CorMatrix Cardiovascular Inc
Average 90 stars, based on 1 article reviews
sis decm patch product corpatch - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Approved dECM medical devices and devices under clinical trials.

Journal: Bioactive Materials

Article Title: Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy

doi: 10.1016/j.bioactmat.2023.10.015

Figure Lengend Snippet: Approved dECM medical devices and devices under clinical trials.

Article Snippet: A SIS dECM patch product, CorPatch (CorMatrix Cardiovascular, Inc) has been approved by FDA.

Techniques: Clinical Proteomics

A commercial epicardial patch for ICM. (A) The CorPatch sheet with 4-layer structure and its components. (B) CorPatch was used as an epicardial patch for infarct myocardial repair. Modified and adapted with permission from Ref. . Copyright 2023, Future Science Group. (C) Cardiac MRI images and regional myocardial perfusion of human left ventricle treated by CorPatch at baseline, 6 week and 6 month. Modified and adapted with permission from Ref. . Copyright 2023, Springer Nature.

Journal: Bioactive Materials

Article Title: Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy

doi: 10.1016/j.bioactmat.2023.10.015

Figure Lengend Snippet: A commercial epicardial patch for ICM. (A) The CorPatch sheet with 4-layer structure and its components. (B) CorPatch was used as an epicardial patch for infarct myocardial repair. Modified and adapted with permission from Ref. . Copyright 2023, Future Science Group. (C) Cardiac MRI images and regional myocardial perfusion of human left ventricle treated by CorPatch at baseline, 6 week and 6 month. Modified and adapted with permission from Ref. . Copyright 2023, Springer Nature.

Article Snippet: A SIS dECM patch product, CorPatch (CorMatrix Cardiovascular, Inc) has been approved by FDA.

Techniques: Modification